EUVIMEDEUVIMED entdecken
Crossref

Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1

Weichu Sun, Jingqi Sun, Wei Hu, Cong Luo, Zhongwei Lu, Fen He, Hongyan Zhao, Xi Zeng, Deliang Cao, Junjun Li, Chang Zhang, Jiliang Xia

Cancer Chemotherapy and Pharmacology · 2025

DOI: 10.1007/s00280-024-04736-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, 2025. Verfasst von Weichu Sun und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Isothiocyanates, Sulfoxides, Cell Proliferation, Cation Transport Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province, PhD Scientific Research Start-up Fund of the University of South China, Scientific Research Project of Hunan Department of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsothiocyanatesSulfoxidesCell ProliferationCation Transport ProteinsCell DifferentiationMacrophagesOsteoclastsMultiple MyelomaAnimalsMiceHumansRAW 264.7 CellsCell Line, TumorFerroportin

Stichwörter der Autor:innen

Ferroportin1MacrophageMultiple myelomaNRF2OsteoclastSulforaphane

Substanzen

IsothiocyanatesFerroportinSulfoxidessulforaphaneCation Transport Proteins

Autor:innen und Institutionen

  • Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, Hunan, China.
  • Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Hunan Province Key Laboratory of Tumor Cellular & Molecular Pathology, Cancer Research Institute, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Hematology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
  • Department of Hematology, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China. anniezhc@163.com.
  • Hunan Engineering Research Center for Early Diagnosis and Treatment of Liver Cancer, Hengyang Medical School, University of South China, Hengyang, Hunan, China. jiliang-xia@usc.edu.cn.

Förderung

  • Natural Science Foundation of Hunan Province
  • PhD Scientific Research Start-up Fund of the University of South China
  • Scientific Research Project of Hunan Department of Education
  • Innovation Platform Open Fund Project of Department of Education of Hunan Province
  • Hunan Provincial Innovation Foundation for Postgraduates
  • National College Student Innovation and Entrepreneurship Training Program

Zitieren

APA

Sun, W., Sun, J., Hu, W., Luo, C., Lu, Z., He, F., Zhao, H., Zeng, X., Cao, D., Li, J., Zhang, C., & Xia, J. (2025). Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1. Cancer Chemotherapy and Pharmacology. https://doi.org/10.1007/s00280-024-04736-7

Vancouver

Sun W, Sun J, Hu W, Luo C, Lu Z, He F, et al. Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1. Cancer Chemotherapy and Pharmacology. 2025. doi:10.1007/s00280-024-04736-7

BibTeX
@article{Sun2025,
  author = {Sun, Weichu and Sun, Jingqi and Hu, Wei and Luo, Cong and Lu, Zhongwei and He, Fen and Zhao, Hongyan and Zeng, Xi and Cao, Deliang and Li, Junjun and Zhang, Chang and Xia, Jiliang},
  title = {Sulforaphane inhibits multiple myeloma cell-induced osteoclast differentiation and macrophage proliferation by elevating ferroportin1},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  doi = {10.1007/s00280-024-04736-7}
}
Kostenlos starten →